Unknown

Dataset Information

0

3D Bioprinted Vascularized Tumour for Drug Testing.


ABSTRACT: An in vitro screening system for anti-cancer drugs cannot exactly reflect the efficacy of drugs in vivo, without mimicking the tumour microenvironment (TME), which comprises cancer cells interacting with blood vessels and fibroblasts. Additionally, the tumour size should be controlled to obtain reliable and quantitative drug responses. Herein, we report a bioprinting method for recapitulating the TME with a controllable spheroid size. The TME was constructed by printing a blood vessel layer consisting of fibroblasts and endothelial cells in gelatine, alginate, and fibrinogen, followed by seeding multicellular tumour spheroids (MCTSs) of glioblastoma cells (U87 MG) onto the blood vessel layer. Under MCTSs, sprouts of blood vessels were generated and surrounding MCTSs thereby increasing the spheroid size. The combined treatment involving the anti-cancer drug temozolomide (TMZ) and the angiogenic inhibitor sunitinib was more effective than TMZ alone for MCTSs surrounded by blood vessels, which indicates the feasibility of the TME for in vitro testing of drug efficacy. These results suggest that the bioprinted vascularized tumour is highly useful for understanding tumour biology, as well as for in vitro drug testing.

SUBMITTER: Han S 

PROVIDER: S-EPMC7215771 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

3D Bioprinted Vascularized Tumour for Drug Testing.

Han Seokgyu S   Kim Sein S   Chen Zhenzhong Z   Shin Hwa Kyoung HK   Lee Seo-Yeon SY   Moon Hyo Eun HE   Paek Sun Ha SH   Park Sungsu S  

International journal of molecular sciences 20200423 8


An in vitro screening system for anti-cancer drugs cannot exactly reflect the efficacy of drugs in vivo, without mimicking the tumour microenvironment (TME), which comprises cancer cells interacting with blood vessels and fibroblasts. Additionally, the tumour size should be controlled to obtain reliable and quantitative drug responses. Herein, we report a bioprinting method for recapitulating the TME with a controllable spheroid size. The TME was constructed by printing a blood vessel layer cons  ...[more]

Similar Datasets

| S-EPMC7945990 | biostudies-literature
2022-09-07 | GSE212669 | GEO
| S-EPMC5074245 | biostudies-literature
| S-EPMC11375967 | biostudies-literature
| PRJNA876718 | ENA
| S-EPMC7939067 | biostudies-literature
| S-EPMC7283506 | biostudies-literature
| S-EPMC9571197 | biostudies-literature
| S-EPMC9295047 | biostudies-literature